BackCVS Health Overview

CVS Health Total Liabilities

Latest total liabilities for CVS: $170B.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$173.87B
↓ 3.83% YoYΔ $-6.92B vs prior year quarter

Peer trimmed avg / median

Loading

CVS Health Total Liabilities History

Loading

CVS Health vs. peers: Total Liabilities Comparison

Loading

CVS Health Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

CVS Health (CVS) FAQ

CVS Health (CVS) currently reports a total liabilities of $170B as of June 2026. That compares with $180B in the prior-year period — down 3.8% year over year. Use the charts on this page to explore CVS Health's total liabilities history and peer comparisons.

CVS Health's total liabilities decreased from $180B to $170B — a 3.8% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

CVS Health reported $170B in total liabilities as of June 2026. That compares with $180B in the prior-year period — down 3.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $170B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for CVS Health, and consider following CVS for alerts when major investors trade the stock.

CVS Health is classified in the Healthcare sector. On total liabilities, it currently shows $170B. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CVS with unrelated industries.